Literature DB >> 24533033

Lipid signals and insulin resistance.

Chongben Zhang1, Eric L Klett2, Rosalind A Coleman1.   

Abstract

The metabolic syndrome, a cluster of metabolic derangements that include obesity, glucose intolerance, dyslipidemia and hypertension, is a major risk factor for cardiovascular disease. Insulin resistance has been proposed to be the common feature that links obesity to the metabolic syndrome, but the mechanism remains obscure. Although the excess content of triacylglycerol in muscle and liver is highly associated with insulin resistance in these tissues, triacylglycerol itself is not causal but merely a marker. Thus, attention has turned to the accumulation of cellular lipids known to have signaling roles. This review will discuss recent progress in understanding how glycerolipids and related lipid intermediates may impair insulin signaling.

Entities:  

Keywords:  acyl-CoA; ceramide; diacylglycerol; lysophosphatidic acid; phosphatidic acid

Year:  2013        PMID: 24533033      PMCID: PMC3921899          DOI: 10.2217/clp.13.67

Source DB:  PubMed          Journal:  Clin Lipidol        ISSN: 1758-4302


  72 in total

1.  Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid-induced ceramide biosynthesis in mice.

Authors:  William L Holland; Benjamin T Bikman; Li-Ping Wang; Guan Yuguang; Katherine M Sargent; Sarada Bulchand; Trina A Knotts; Guanghou Shui; Deborah J Clegg; Markus R Wenk; Michael J Pagliassotti; Philipp E Scherer; Scott A Summers
Journal:  J Clin Invest       Date:  2011-04-01       Impact factor: 14.808

2.  Insulin resistance. Prosperity's plague.

Authors:  Gary Taubes
Journal:  Science       Date:  2009-07-17       Impact factor: 47.728

3.  Long-chain acyl-CoA esters as indicators of lipid metabolism and insulin sensitivity in rat and human muscle.

Authors:  B A Ellis; A Poynten; A J Lowy; S M Furler; D J Chisholm; E W Kraegen; G J Cooney
Journal:  Am J Physiol Endocrinol Metab       Date:  2000-09       Impact factor: 4.310

4.  A role for protein phosphatase 2A-like activity, but not atypical protein kinase Czeta, in the inhibition of protein kinase B/Akt and glycogen synthesis by palmitate.

Authors:  R Cazzolli; L Carpenter; T J Biden; C Schmitz-Peiffer
Journal:  Diabetes       Date:  2001-10       Impact factor: 9.461

5.  Diabetes mellitus is associated with increased intramyocellular triglyceride, but not diglyceride, content in obese humans.

Authors:  Costas A Anastasiou; Stavros A Kavouras; Yannis Lentzas; Afrodite Gova; Labros S Sidossis; Adreas Melidonis
Journal:  Metabolism       Date:  2009-07-16       Impact factor: 8.694

6.  Blocking VLDL secretion causes hepatic steatosis but does not affect peripheral lipid stores or insulin sensitivity in mice.

Authors:  Kaori Minehira; Stephen G Young; Claudio J Villanueva; Laxman Yetukuri; Matej Oresic; Mark K Hellerstein; Robert V Farese; Jay D Horton; Frederic Preitner; Bernard Thorens; Luc Tappy
Journal:  J Lipid Res       Date:  2008-06-01       Impact factor: 5.922

7.  Regulation of mTORC1 and mTORC2 complex assembly by phosphatidic acid: competition with rapamycin.

Authors:  Alfredo Toschi; Evan Lee; Limei Xu; Avalon Garcia; Noga Gadir; David A Foster
Journal:  Mol Cell Biol       Date:  2008-12-29       Impact factor: 4.272

Review 8.  Autotaxin--an LPA producing enzyme with diverse functions.

Authors:  Keita Nakanaga; Kotaro Hama; Junken Aoki
Journal:  J Biochem       Date:  2010-05-21       Impact factor: 3.387

9.  Inhibition of de novo ceramide synthesis reverses diet-induced insulin resistance and enhances whole-body oxygen consumption.

Authors:  John R Ussher; Timothy R Koves; Virgilio J J Cadete; Liyan Zhang; Jagdip S Jaswal; Suzanne J Swyrd; David G Lopaschuk; Spencer D Proctor; Wendy Keung; Deborah M Muoio; Gary D Lopaschuk
Journal:  Diabetes       Date:  2010-06-03       Impact factor: 9.461

Review 10.  Diacylglycerol activation of protein kinase Cε and hepatic insulin resistance.

Authors:  François R Jornayvaz; Gerald I Shulman
Journal:  Cell Metab       Date:  2012-05-02       Impact factor: 27.287

View more
  12 in total

1.  Identification of a mammalian glycerol-3-phosphate phosphatase: Role in metabolism and signaling in pancreatic β-cells and hepatocytes.

Authors:  Yves Mugabo; Shangang Zhao; Annegrit Seifried; Sari Gezzar; Anfal Al-Mass; Dongwei Zhang; Julien Lamontagne; Camille Attane; Pegah Poursharifi; José Iglesias; Erik Joly; Marie-Line Peyot; Antje Gohla; S R Murthy Madiraju; Marc Prentki
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-11       Impact factor: 11.205

2.  Small lipidated anti-obesity compounds derived from neuromedin U.

Authors:  Ewa D Micewicz; Omar S O Bahattab; Gary B Willars; Alan J Waring; Mohamad Navab; Julian P Whitelegge; William H McBride; Piotr Ruchala
Journal:  Eur J Med Chem       Date:  2015-07-14       Impact factor: 6.514

3.  Inhibited insulin signaling in mouse hepatocytes is associated with increased phosphatidic acid but not diacylglycerol.

Authors:  Chongben Zhang; Gwen Hwarng; Daniel E Cooper; Trisha J Grevengoed; James M Eaton; Viswanathan Natarajan; Thurl E Harris; Rosalind A Coleman
Journal:  J Biol Chem       Date:  2014-12-15       Impact factor: 5.157

Review 4.  Lipidomics for studying metabolism.

Authors:  Xianlin Han
Journal:  Nat Rev Endocrinol       Date:  2016-07-29       Impact factor: 43.330

5.  Metabogenomics reveals four candidate regions involved in the pathophysiology of Equine Metabolic Syndrome.

Authors:  Laura Patterson Rosa; Martha F Mallicote; Maureen T Long; Samantha A Brooks
Journal:  Mol Cell Probes       Date:  2020-07-10       Impact factor: 2.365

6.  mRNA expression of diacylglycerol kinase isoforms in insulin-sensitive tissues: effects of obesity and insulin resistance.

Authors:  Louise Mannerås-Holm; Henriette Kirchner; Marie Björnholm; Alexander V Chibalin; Juleen R Zierath
Journal:  Physiol Rep       Date:  2015-04

7.  n-3 Fatty acids attenuate the risk of diabetes associated with elevated serum nonesterified fatty acids: the multi-ethnic study of atherosclerosis.

Authors:  Brian T Steffen; Lyn M Steffen; Xia Zhou; Pamela Ouyang; Natalie L Weir; Michael Y Tsai
Journal:  Diabetes Care       Date:  2015-01-08       Impact factor: 19.112

8.  Triglyceride profiling in adipose tissues from obese insulin sensitive, insulin resistant and type 2 diabetes mellitus individuals.

Authors:  Haya Al-Sulaiti; Ilhame Diboun; Sameem Banu; Mohamed Al-Emadi; Parvaneh Amani; Thomas M Harvey; Alex S Dömling; Aishah Latiff; Mohamed A Elrayess
Journal:  J Transl Med       Date:  2018-06-26       Impact factor: 5.531

9.  Potential Protection Against Type 2 Diabetes in Obesity Through Lower CD36 Expression and Improved Exocytosis in β-Cells.

Authors:  Mototsugu Nagao; Jonathan L S Esguerra; Akira Asai; Jones K Ofori; Anna Edlund; Anna Wendt; Hitoshi Sugihara; Claes B Wollheim; Shinichi Oikawa; Lena Eliasson
Journal:  Diabetes       Date:  2020-03-20       Impact factor: 9.461

10.  Significant alteration of liver metabolites by AAV8.Urocortin 2 gene transfer in mice with insulin resistance.

Authors:  Young Chul Kim; Agnieszka D Truax; Dimosthenis Giamouridis; N Chin Lai; Tracy Guo; H Kirk Hammond; Mei Hua Gao
Journal:  PLoS One       Date:  2019-12-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.